27 research outputs found
PRS4 AN ECONOMIC EVALUATION OF FIRST LINE ANTIBIOTICS FOR THE INPATIENT TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS IN MEXICO
Get PDFPIN36 THE ECONOMIC IMPACT OF MARAVIROC FOR ANTIRETROVIRAL TREATMENT-EXPERIENCED HIV-INFECTED INDIVIDUALS IN MEXICO
Get PDFDB2 COST-EFFECTIVENESS ANALYSIS OF PREGABALIN FOR THE MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY IN MEXICO
Get PDFPCV52 ECONOMIC EVALUATION OF DALTEPARIN FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) AFTER TOTAL KNEE ARTHROPLASTY IN MEXICO
Get PDFPCV21 ECONOMIC EVALUATION OF EPLERENONE COMPARED WITH PLACEBO IN PATIENTS WITH MYOCARDIAL INFARCTION COMPLICATED BY LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AND HEART FAILURE IN MEXICO
No full textPCV25 THE ECONOMIC AND HEALTH CONSEQUENCES IN MEXICO OF MANAGING HYPERTENSION AND HYPERCHOLESTEROLEMIA WITH A SINGLE PILL THERAPY
No full textPRS5 COST—EFFECTIVENESS ANALYSIS OF FIRST LINE ANTIBIOTICS FOR THE INPATIENT TREATMENT OF PATIENTS WITH COMMUNITY ACQUIRE PNEUMONIA IN A PUBLIC MEXICAN HOSPITAL
No full textPSY20 COST-EFFECTIVENESS ANALYSIS OF IMMUNOSUPPRESSIVE TREATMENTS FOR BONE MARROWTRANSPLANTATION IN PATIENTS WITH APLASTIC ANEMIA IN MEXICO
No full textPUK10 ECONOMIC EVALUATION OF POLYCLONAL ANTIBODIES FOR THE MANAGEMENT OF HIGH RISK PATIENTS WITH ACUTE REJECTION IN RENAL TRANSPLANTATION AT THE SOCIAL SECURITY MEXICAN INSTITUTE (IMSS)
No full textPIN36 THE ECONOMIC IMPACT OF MARAVIROC FOR ANTIRETROVIRAL TREATMENT-EXPERIENCED HIV-INFECTED INDIVIDUALS IN MEXICO
No full text
